Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $26,780 - $29,800
-166 Reduced 8.16%
1,868 $307,000
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $342,098 - $378,344
2,034 New
2,034 $359,000
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $303,470 - $344,633
-1,919 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $9,979 - $11,072
64 Added 3.45%
1,919 $328,000
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $10,820 - $12,024
67 Added 3.75%
1,855 $299,000
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $797 - $855
-5 Reduced 0.28%
1,788 $296,000
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $24,338 - $27,106
159 Added 9.73%
1,793 $294,000
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $11,928 - $13,692
87 Added 5.62%
1,634 $258,000
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $217,167 - $237,975
1,547 New
1,547 $229,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.